Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Clonal evolution and therapeutic vulnerabilities in SETBP1-mutated leukemia: Insights from physiological mouse model and integrative functional screens

View Full Paper
Ask AI
Bookmark
Share

Authors

KNKoutarou NishimuraATAtsushi TanakaMMMasashi Matsuda

Discussion

Loading...

Member takes

Overview

Observational analysis shows monocytosis in SETBP1-mutated leukemia, indicating chromatin regulators might be critical targets.

Key Points

  • Monocytosis of ~40% was observed in interactive SETBP1-mutated leukemia models, indicating potential biomarkers for progression.
  • Key functional roles of chromatin dynamics were illuminated by measuring changes in leukemogenic genes linked to these mutations.
  • Investigation utilized blood-specific Setbp1 mutant knock-in mouse models to explore Eya1 and Myb functional roles in leukemia advancement.
  • Study emphasizes the urgency of targeting chromatin regulation for enhanced treatment efficacy in leukemia management.

Cite This Study

Nishimura et al. (2025) studied this question.

synapsesocial.com/papers/69362f764fa91c937236e37bhttps://doi.org/10.1182/blood-2025-989
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clone-specific epigenetic regulatory mechanisms in ASXL1-mutant chronic myelomonocytic leukemia2025
  2. 2SETD2 deficiency in chronic myeloid leukemia (CML) contributes to tyrosine kinase inhibitor (TKI) resistance and disease acceleration by enhancing genetic instability and rewiring cellular metabolism and might be a novel biomarker of high risk disease since diagnosis2025
  3. 3Pre-malignant extracellular matrix drives leukemia transformation through reprogramming of pre-leukemic stem cells2025
  4. 4Co‐operative epigenetic remodelling by Setd2 deficiency and Kras mutation drives juvenile myelomonocytic leukaemia development and MEK inhibitor sensitivity2025 · 2 citations
  5. 5Chromatin remodeler SATB2 thorough Bmi1/PRC1 activity controls transformation and reprogramming of ph+ B-cell progenitors2025